Literature DB >> 2789140

The biochemical characterization of E2, a T cell surface molecule involved in rosettes.

F Aubrit1, C Gelin, D Pham, B Raynal, A Bernard.   

Abstract

We have previously identified a molecule on the T cell surface, which, in addition to CD2 is involved in the rosette phenomenon. This is a 32-kDa single polypeptide chain which we have termed E2. The studies reported here show striking patterns on the glycosylation status of E2. It is a heavily sialylated and glycosylated molecule, the sugar moieties accounting for almost half of its relative molecular mass (Mr). It carries no N-linked sugar residues, only O-linked oligosaccharides. Despite heavy glycosylation, the molecule appears to behave homogeneously on gel electrophoresis, both in terms of Mr and pI. Neuraminidase treatment of E2 lowered its Mr to 28 kDa; this was further decreased to 18 kDa after removal of O-linked sugar residues by treatment with O-glycanase. An identical reduction in size was observed after treatment with trifluoromethane sulfonic acid, showing that the molecule carries no detectable N-linked sugar residues. Moreover, endoglycosidase F and endoglycosidase H treatment of either the immunoprecipitates from 125I surface-labeled thymocytes, or of a purified preparation of E2, did not reduce the Mr of E2, nor did tunicamycin treatment of T cells. Two-dimensional gel electrophoresis revealed two discrete spots of acidic pI (4.4 and 4.6) that were still seen after neuraminidase treatment, though they had moderately shifted. Pulse-chase experiments revealed a single 28-kDa precursor form that could have been the unsialylated molecule. Finally, sequencing 14 amino acid residues of the N-terminal side revealed no homology with known proteins. Since the sugar moieties of adhesion protein could play an important role, the results obtained in this study will prove valuable to our understanding of the role exerted by the E2 molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789140     DOI: 10.1002/eji.1830190813

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Gingipains of Porphyromonas gingivalis modulate leukocyte adhesion molecule expression induced in human endothelial cells by ligation of CD99.

Authors:  Peter L W Yun; Arthur A Decarlo; Neil Hunter
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 2.  CD99 in malignant hematopoiesis.

Authors:  Atham Ali; Vijaya Pooja Vaikari; Houda Alachkar
Journal:  Exp Hematol       Date:  2021-12-14       Impact factor: 3.249

3.  Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.

Authors:  Nuchjira Takheaw; Gunya Sittithumcharee; Ryusho Kariya; Watchara Kasinrerk; Seiji Okada
Journal:  Cancer Immunol Immunother       Date:  2020-11-19       Impact factor: 6.968

4.  Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.

Authors:  Haydar Çelik; Marika Sciandra; Bess Flashner; Elif Gelmez; Neslihan Kayraklıoğlu; David V Allegakoen; Jeff R Petro; Erin J Conn; Sarah Hour; Jenny Han; Lalehan Oktay; Purushottam B Tiwari; Mutlu Hayran; Brent T Harris; Maria Cristina Manara; Jeffrey A Toretsky; Katia Scotlandi; Aykut Üren
Journal:  Oncogene       Date:  2018-01-31       Impact factor: 9.867

5.  4D intravital microscopy uncovers critical strain differences for the roles of PECAM and CD99 in leukocyte diapedesis.

Authors:  David P Sullivan; Richard L Watson; William A Muller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-15       Impact factor: 4.733

6.  Erythrocyte receptor (CD2)-bearing T lymphocytes are affected by diet in experimental pulmonary tuberculosis.

Authors:  R A Bartow; D N McMurray
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.

Authors:  Larizbeth A Romero; Takamitsu Hattori; Mohamed A E Ali; Gayatri Ketavarapu; Akiko Koide; Christopher Y Park; Shohei Koide
Journal:  J Mol Biol       Date:  2021-12-24       Impact factor: 5.469

8.  Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses.

Authors:  Supansa Pata; Pavel Otáhal; Tomáš Brdička; Witida Laopajon; Kodchakorn Mahasongkram; Watchara Kasinrerk
Journal:  BMC Res Notes       Date:  2011-08-13

Review 9.  CD99 at the crossroads of physiology and pathology.

Authors:  Michela Pasello; Maria Cristina Manara; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2018-01-06       Impact factor: 5.782

10.  Targeting Tumor Vascular CD99 Inhibits Tumor Growth.

Authors:  Elisabeth J M Huijbers; Inge M van der Werf; Lisette D Faber; Lena D Sialino; Pia van der Laan; Hanna A Holland; Anca M Cimpean; Victor L J L Thijssen; Judy R van Beijnum; Arjan W Griffioen
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.